Surging clinical investments in precision nucleic acid therapeutics, expanding drug pipelines for rare neuromuscular and neurodegenerative disorders, and continuous chemical modifications in targeted oligonucleotide backbones are driving rapid growth across the global Antisense Oligonucleotide Therapeutics Pipeline Insight Market. Antisense oligonucleotide (ASO) therapeutics—comprising...
